Article
Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection
medRxiv · 2020 · Haddad, N. S.; Nguyen, D. C.; Kuruvilla, M. E.; Morrison-Porter, A.; Anam, F.; Cashman, K. S.; Ramonell, R. P.; Kyu, S.; Saini, A. S.; Cabrera-Mora, M.; Derrico, A.; Alter, D.; Roback, J. D.; Horwath, M.; O'Keefe, J. B.; Wu, H. M.; Wong, A.-K. I.; Dretler, A. W.; Gripaldo, R.; Lane, A. N.; Wu, H.; Lee, S.; Hernandez, M.; Engineer, V.; Varghese, J.; Le, S.; Sanz, I.; Daiss, J. L.; Lee, F. E.-H.
Key facts
| Title | Elevated SARS-CoV-2 Antibodies Distinguish Severe Disease in Early COVID-19 Infection |
|---|---|
| First author | Haddad, N. S.; Nguyen, D. C.; Kuruvilla, M. E.; Morrison-Porter, A.; Anam, F.; Cashman, K. S.; Ramonell, R. P.; Kyu, S.; Saini, A. S.; Cabrera-Mora, M.; Derrico, A.; Alter, D.; Roback, J. D.; Horwath, M.; O'Keefe, J. B.; Wu, H. M.; Wong, A.-K. I.; Dretler, A. W.; Gripaldo, R.; Lane, A. N.; Wu, H.; Lee, S.; Hernandez, M.; Engineer, V.; Varghese, J.; Le, S.; Sanz, I.; Daiss, J. L.; Lee, F. E.-H. |
| Journal | medRxiv |
| Published | Dec 6, 2020 |
| DOI | 10.1101/2020.12.04.410589 |
| Devices mentioned | K121399, K133302, K822496 |
| Product codes mentioned | JIT, NSU |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1